Australian biotechs attract strong interest at US investor meeting
Monday, 23 January, 2012
For the fifth year, AusBiotech has managed a presentation of Australian companies to San Francisco for an investor showcase held in conjunction with invitation-only the 30th JP Morgan Annual Healthcare Conference in the US.
The event held on the 9 January was again successful in attracting investors – this year 280, with a large contingent from China and Hong Kong – providing a valuable platform for Australian companies seeking investment and partnerships. Presenting companies included:
- Alchemia (ASX:ACL)
- Genetic Technologies (ASX:GTG)
- Phylogica (ASX:PYC)
- Sunshine Heart (ASX:SHC)
- Uptake Medical
- Viveve
AusBiotech has established a calendar of international and local investor showcase events. The next events on the international calendar are:
- Australian Life Science Showcase: Hong Kong 2012 - Wednesday 23 May 2012
- Australian Life Science Showcase: New York 2012 - Friday 15 June 2012 (just prior to BIO2012 convention in Boston)
- Australian Life Science Showcase: Edinburgh 2012 -Wednesday 3 October 2012
- Australian Life Science Showcase: London 2012 - Friday 5 October 2012
Upcoming local events include:
- ‘Brokers meet Biotech' Luncheon - Tuesday 28 February 2012, Melbourne, Victoria
- Medtech Investment Showcase - Monday 14 May 2012 (preceding AusMedtech annual conference), Sydney
- Australasian Life Sciences Investment Summit 2012 - Friday 2 November (part of the AusBiotech 2012 conference), Melbourne
For further information see www.ausbiotech.org/investment.
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
Females found to carry a higher genetic risk of depression
An international team of scientists has discovered about twice as many genetic 'flags'...
